22 S Greene StBaltimore, MD 21201
Fax+1 410-328-0697
Overview of Dr. Ahmad
Dr. Haroon Ahmad is a neuro-oncologist based in Baltimore, MD, with an impressive educational background. He completed his undergraduate studies at the University of Maryland, BC and pursued a Medical Degree at the University of Virginia School of Medicine. Furthering his specialization, he completed a residency and a chief residency in Neurology at Rutgers Health/Robert Wood Johnson Medical School, and a Fellowship in Neuro-Oncology at the University of Virginia Medical Center. Currently, he serves as an Assistant Professor at the University of Maryland Medical Center. A cited author in numerous publications, Dr. Ahmad has substantial contributions to the field, particularly on novel therapeutics in the treatment of gliomas.
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2019
Rutgers Health/Robert Wood Johnson Medical SchoolChief Residency, Neurology, 2016 - 2017- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Neurology, 2013 - 2017
ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 2013 - 2014
University of Virginia School of MedicineClass of 2012, MD
University of Maryland, Baltimore CountyBS, Biochemistry, Cum Laude, 2003 - 2007
Certifications & Licensure
MD State Medical License 2019 - 2026
VA State Medical License 2017 - 2024
NJ State Medical License 2014 - 2018
NC State Medical License 2013 - 2014
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Baltimore Top Doctor Baltimore Magazine, 2024
Publications & Presentations
PubMed
- Correction: Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.Ali M Saeed, Søren M Bentzen, Haroon Ahmad, Lily Pham, Graeme F Woodworth
Radiation Oncology. 2024-05-15 - 1 citationsSystematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.Ali M Saeed, Søren M Bentzen, Haroon Ahmad, Lily Pham, Graeme F Woodworth
Radiation Oncology. 2024-03-14 - 3 citationsTreatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.Kathryn Kline, Tim Luetkens, Rima Koka, Michael E Kallen, Wengen Chen
Cancer Immunology, Immunotherapy. 2024-02-13
Press Mentions
Clinical Trial Aids Chestertown Man in Beating Aggressive CancerMarch 1st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
